1. lncRNA HULC promotes the growth of hepatocellular carcinoma cells via stabilizing COX-2 protein
   Haojun Xiong et al, 2017, Biochemical and Biophysical Research Communications CrossRef
2. New advances of lncRNAs in liver fibrosis, with specific focus on lncRNA–miRNA interactions
   Er‐Bao Bian et al, 2019, Journal of Cellular Physiology CrossRef
3. Lnc-TCL6 is a potential biomarker for early diagnosis and grade in liver-cirrhosis patients
   Lei-Jia Li et al, 2019, Gastroenterology Report CrossRef
4. Dysregulation of HULC promotes contrast-induced nephropathy (CIN) via regulating signaling pathway of miRNA-512 and prostaglandin E1 (PGE1)
   Liang Zhang et al, 2020, Scientific Reports CrossRef
5. The importance of long non-coding RNAs in neuropsychiatric disorders
   Ebrahim Hosseini et al, 2019, Molecular Aspects of Medicine CrossRef
6. Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers
   Olfa Khalifa et al, 2020, Disease Markers CrossRef
7. Advances of Long Non-Coding RNAs as Potential Biomarkers for Tuberculosis: New Hope for Diagnosis?
   Jiaojiao Xia et al, 2023, Pharmaceutics CrossRef
8. Noncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma
   Zhixia Zhou et al, 2022, Molecular Therapy - Oncolytics CrossRef
9. The transcriptomic profile shows the protective effects of celecoxib on cirrhotic splenomegaly
   Yanting Ye et al, 2024, Immunopharmacology and Immunotoxicology CrossRef
10. Mechanisms of Xiaochaihu Decoction on Treating Hepatic Fibrosis Explored by Network Pharmacology
    Rui Qiang et al, 2022, Disease Markers CrossRef
11. Treatment with either COX‐2 inhibitor or 5‐LOX inhibitor causes no compensation between COX‐2 pathway and 5‐LOX pathway in chronic aluminum overload‐induced liver injury in rats
    Hui Xia et al, 2019, Fundamental & Clinical Pharmacology CrossRef
12. CRISPR/Cas9 knockout of Ptgs2 promotes apoptosis of hepatic stellate cells
    Hongyu Zhou et al, 2024, Clinics and Research in Hepatology and Gastroenterology CrossRef
13. Celecoxib reduces hepatic vascular resistance in portal hypertension by amelioration of endothelial oxidative stress
    Yang Tai et al, 2021, Journal of Cellular and Molecular Medicine CrossRef
14. Long non-coding RNAs in metabolic disorders: pathogenetic relevance and potential biomarkers and therapeutic targets
    B. Alipoor et al, 2021, Journal of Endocrinological Investigation CrossRef
15. Impact of knockdown LincRNA-Cox2 on apoptosis of macrophage infected with Bacillus Calmette-Guérin
    Yanan Xu et al, 2021, Molecular Immunology CrossRef
16. Clinical application and pharmacological mechanism of Wuling powder in the treatment of ascites: A systematic review and network pharmacological analysis
    Yue Mou et al, 2022, Biomedicine & Pharmacotherapy CrossRef
17. Celecoxib ameliorates liver cirrhosis via reducing inflammation and oxidative stress along spleen-liver axis in rats
    Shihang Tang et al, 2021, Life Sciences CrossRef
18. Role of Non-Coding RNAs in the Progression of Liver Cancer: Evidence from Experimental Models
    April O’Brien et al, 2019, Cancers CrossRef
19. Gamma irradiation-induced liver injury and its amelioration by red ginseng extract
    Seon-A Jang et al, 2017, Molecular & Cellular Toxicology CrossRef
20. Epigenetics and mitochondrial dysfunction insights into the impact of the progression of non‐alcoholic fatty liver disease
    Shreyoshi Guha et al, 2023, Cell Biochemistry and Function CrossRef
21. Sulforaphane, polyphenols and related anti-inflammatory and antioxidant activities changes of Egyptian broccoli during growth
    Raef Shams et al, 2017, Journal of Food Measurement and Characterization CrossRef
22. LincRNA Cox-2 Regulates Lipopolysaccharide-Induced Inflammatory Response of Human Peritoneal Mesothelial Cells via Modulating miR-21/NF-κB Axis
    Yaoyao Bian et al, 2019, Mediators of Inflammation CrossRef
23. Detection of COX-2 in liquid biopsy in patients with breast cancer
    Camilla Paulla de Souza et al, 2020, Journal of Clinical Pathology CrossRef
24. Assessment of animal experimental models of toxic liver injury in the context of their potential application as preclinical models for cell therapy
    Piotr Czekaj et al, 2019, European Journal of Pharmacology CrossRef
25. LncRNA: Shedding light on mechanisms and opportunities in fibrosis and aging
    Zhi Yang et al, 2019, Ageing Research Reviews CrossRef